Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) Restructuring Costs (2019 - 2020)

Dna X (SONM) has disclosed Restructuring Costs for 2 consecutive years, with $459000.0 as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Restructuring Costs rose 190.51% year-over-year to $459000.0, compared with a TTM value of $2.1 million through Dec 2020, changed N/A, and an annual FY2024 reading of $514000.0, changed N/A over the prior year.
  • Restructuring Costs was $459000.0 for Q4 2020 at Dna X, down from $527000.0 in the prior quarter.
  • Across five years, Restructuring Costs topped out at $1.1 million in Q1 2020 and bottomed at $158000.0 in Q4 2019.